Table of Contents
Chapter 1. Executive Summary
1.1. Yersinia Diagnostics – Industry Summary and Critical Success Factors (CSFs)
Chapter 2. Yersinia Diagnostics Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Yersinia Diagnostics Market Dynamics
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Yersinia Diagnostics - Company Market Share Analysis
2.7. Yersinia Diagnostics Market PESTEL Analysis, 2012
Chapter 3. Yersinia Diagnostics Product Outlook
3.1. Molecular Diagnostics
3.2. Gel Microdroplets
3.3. Liposomes
3.4. Monoclonal Antibodies
3.5. Healthcare Information Technology
3.6. Flow Cytometry
3.7. Chromatography
3.8. Artificial Intelligence
3.9. Immunoassays
3.10. Differential Light Scattering
3.11. Diagnostic Imaging
3.12. Others
Chapter 4. Yersinia Diagnostics End-User Outlook
4.1. Hospitals
4.2. Public Health Laboratories
4.3. Commercial Laboratories
4.4. Others
Chapter 5. Yersinia Diagnostics Regional Outlook
5.1. North America
5.2. Europe
5.3. Asia-Pacific
5.4. RoW
Chapter 6. Competitive Landscape
6.1. Revenue Analysis
6.2. Product Benchmarking
6.3. Strategic Development
Chapter 7. Methodology and Scope
7.1. Research Methodology
7.2. Research Scope & Assumption
7.3. List of Data Sources